John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
CDC Provides Additional Data on RSV Vaccines’ Safety, Rationale on Recommendations
August 7th 2024In this week’s edition of MMWR, the Centers for Disease Control and Prevention reported on the vaccines’ safety profile for each of the FDA approved immunizations and rationale for the recommended age groups.
Read More
WHO: Prepare to Identify Hypervirulent Pathogen
Published: August 5th 2024 | Updated: August 5th 2024The World Health Organization (WHO) warns of a moderate global risk to the presence of the pathogen, hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23, as it has been reported in at least 1 country in all 6 WHO Regions.
Read More
The Evolution of Lenacapavir in HIV Treatment
Published: July 24th 2024 | Updated: July 25th 2024The antiviral began its development as a multidrug-resistant therapy for people with HIV, and has since been studied as PrEP intervention, with many now calling for it to be made widely available for mass distribution.
Read More
The Chasm Between the Scientific Method and How Medical Information is Understood
July 18th 2024The disconnect between evolving science and medical communication has left people confused about how to interpret public health information, and provided an opportunity for vaccine deniers and politicians to give disinformation on COVID-19.
Read More
cUTI Roundtable: Discussing and Diagnosing These Difficult Infections
July 10th 2024This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.
Read More